Diagnosis of congenital toxoplasmosis in the neonatal period: A multicenter evaluation

Journal of Pediatrics

Volumn 135, Issue 6, 1999, Pages 714-719

  Naessens, Anne ^{a,b,c,d,e,f,g,h,i}   Jenum, Pål A ^{a,b,c,d,e,f,g,h}   Pollak, Arnold ^{a,b,c,d,e,f,g,h}   Decoster, Anne ^{a,b,c,d,e,f,g,h}   Lappalainen, Maija ^{a,b,c,d,e,f,g,h}   Villena, Isabelle ^{a,b,c,d,e,f,g,h}   Lebech, Morten ^{a,b,c,d,e,f,g,h}   Stray Pedersen, Babill ^{a,b,c,d,e,f,g,h}   Hayde, Michael ^{a,b,c,d,e,f,g,h}   Pinon, Jean Michel ^{a,b,c,d,e,f,g,h}   Petersen, Eskild ^{a,b,c,d,e,f,g,h}   Foulon, Walter ^{a,b,c,d,e,f,g,h}  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d Laboratoire du CH St Vincent   (France)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f Laboratoire de Parasitologie   (France)

^g STATENS SERUM INSTITUT   (Denmark)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CLINICAL TRIAL; CONGENITAL TOXOPLASMOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NEWBORN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; SEROCONVERSION; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 0033497102     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3476(99)70090-9     Document Type: Article

References (34)

1. 1. Remington JS, McLeod R, Desmonts G. Toxoplasmosis. In: Remington JS, Klein JO, editors. Infectious diseases of the fetus and newborn infants. 4th ed. Philadelphia: WB Saunders; 1995. p. 140-267.
2. 2. Wilson CB, Remington JS, Stagno S, Reynolds DW. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics 1980;66:767-74.
3. 3. Koppe JG, Loewer-Sieger DH, de Roever-Bonnet H. Results of 20 year follow-up of congenital toxoplasmosis. Lancet 1986;101:254-5.
4. 4. Pinon JM, Chemla C, Villena I, Foudrinier F, Aubert D, Puygauthier-Toubas D, et al. Early neonatal diagnosis of congenital toxoplasmosis: value of comparative enzyme-linked immunofiltration assay immunological profiles and anti-Toxoplasma gondii immunoglobulin M (IgM) or IgA immunocapture and implications for postnatal therapeutic strategies. J Clin Microbiol 1996;34:579-83.
5. 5. McAuley J, Boyer KM, Patel D, Mets M, Swisher C, Roizen N, et al. Early and longitudinal evaluation of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago collaborative treatment trial. Clin Infect Dis 1994;18:38-72.
6. 6. Jenum PA, Stray-Pedersen B. Development of specific immunoglobulins G, M, and A following primary Toxoplasma gondii infection in pregnant women. J Clin Microbiol 1998;36:2907-13.
7. 7. Foulon W, Villena I, Stray-Pedersen B, Decoster A, Lappalainen M, Pinon JM, et al. Treatment of toxoplasmosis during pregnancy: a multicenter study of impact on fetal transmission and children's sequelae at age 1 year. Am J Obstet Gynecol 1999;190:410-5.
8. 8. Foulon W, Naessens A, Volckaert M, Lauwers S, Amy JJ. Congenital toxoplasmosis: a prospective survey in Brussels. Br J Obstet Gynaecol 1984; 91:419-23.
9. 9. Jenum PA, Stray-Pedersen B, Melby KK, Kapperud G, Whitelaw A, Eskild A, et al. Incidence of Toxoplasma gondii infection in 35,940 pregnant women in Norway and pregnancy outcome for infected women. J Clin Microbiol 1998;36:2900-6.
10. 10. Aspock H, Pollak A. Prevention of prenatal toxoplasmosis by serological screening of pregnant women in Austria. Scand J Infect Dis 1992;84(suppl):32-7.
11. 11. Eaton RB, Petersen E, Seppanen H, Tuuminen T. Multicenter evaluation of a fluorometric enzyme immunocapture assay to detect Toxoplasma-specific immunoglobulin M in dried blood filter paper specimens from newborns. J Clin Microbiol 1996;34:3147-50.
12. 12. Lappalainen M, Koskiniemi M, Hiilesmaa V, Ammala P, Teramo K, Koskela P, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. The Study Group. Pediatr Infect Dis J 1995;14:354-61.
13. 13. Decoster A, Darcy F, Caron A, Capron A. IgA antibodies against P30 as markers of congenital and acute toxoplasmosis. Lancet 1988;2:1104-7.
14. 14. Lebech M, Joynson DH, Seitz HM, Thulliez P, Gilbert RE, Dutton GN, et al. Classification system and case definitions of Toxoplasma gondii infection in immunocompetent pregnant women and their congenitally infected offspring. European Research Network on Congenital Toxoplasmosis. Eur J Clin Microbiol Infect Dis 1996;15:799-805.
15. 15. Hohlfeld P, Daffos F, Costa JM, Thulliez P, Forestier F, Vidaud M. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994; 331:695-9.
16. 16. Villena I, Aubert D, Leroux B, Dupouy D, Talmud M, Chemla C, et al. Pyrimethamine-sulfadoxine treatment of congenital toxoplasmosis: follow-up of 78 cases between 1980 and 1997. Reims Toxoplasmosis Group. Scand J Infect Dis 1998;30:295-300.
17. 17. Kapperud G, Jenum PA, Stray-Pedersen B, Melby KK, Eskild A, Eng J. Risk factors for Toxoplasma gondii infection in pregnancy. Results of a prospective case-control study in Norway. Am J Epidemiol 1996;144:405-12.
18. 18. Foulon W, Naessens A, Derde MP. Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatol 1994;11:57-62.
19. 19. Villena I, Quereux C, Pinon JM. Congenital toxoplasmosis: value of prenatal treatment with pyrimethamine-sulfadoxine combination [letter]. Prenat Diagn 1998;18:754-5.
20. 20. Lappalainen M, Koskela P, Hedman K, Teramo K, Ämmälä P, Hiilesmaa V, et al. Incidence of primary Toxoplasma infections during pregnancy in southern Finland: a prospective cohort study. Scand J Infect Dis 1992;24:97-104.
21. 21. Gratzl R, Hayde M, Kohlhanser C, Hermon M, Burda G, Strobl W, et al. Follow up of infants with congenital toxoplasmosis detected by polymerase chain reaction analysis of amniotic fluid. Eur J Clin Microbiol Infect Dis 1998;17:853-8.
22. 22. Thulliez P. Screening programme for congenital toxoplasmosis in France. Scand J Infect Dis 1992;84(suppl):43-5.
23. 23. Lappalainen M, Koskiniemi M, Hiilesmaa V, Ämmälä P, Teramo K, Koskela P, et al. Outcome of children after maternal primary Toxoplasma infection during pregnancy with emphasis on avidity of specific IgG. Pediatr Infect Dis J 1995;14:354-61.
24. 24. Lebech M, Andersen O, Christensen NJ, Hertel J, Nielsen HE, Peitersen B, et al. Feasibility of neonatal screening for toxoplasma infection in the absence of prenatal treatment. Lancet 1999;353:1834-7.
25. 25. Guerina NG, Hsu HW, Meissner HC, Maguire JH, Lynfield R, Stechenberg B, et al. Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. The New England Regional Toxoplasma Working Group. N Engl J Med 1994;330:1858-63.
26. 26. Decoster A, Slizewicz B, Simon J, Bazin C, Darcy F, Vittu G, et al. Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol 1991;29:2291-5.
27. 27. Stepick-Biek P, Thulliez P, Araujo FG, Remington JS. IgA antibodies for diagnosis of acute congenital and acquired toxoplasmosis. J Infect Dis 1990;162:270-3.
28. 28. Bessières MH, Roques C, Berrebi A, Barre V, Cazaux M, Seguela JP. IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 1992;45:605-8.
29. 29. Naot Y, Desmonts G, Remington JS. IgM enzyme-linked immunosorbent assay test for the diagnosis of congenital Toxoplasma infection. J Pediatr 1981;98:32-6.
30. 30. Pricker-Hidalgo H, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A, Ambroise-Thomas P. Congenital toxoplasmosis: specific IgM in fetal blood, cord blood and in the newborn. Ann Biol Clin (Paris) 1996;54:165-8.
31. 31. Chumpitazi BF, Boussaid A, Pelloux H, Racinet C, Bost M, Goullier-Fleuret A. Diagnosis of congenital toxoplasmosis by immunoblotting and relationship with other methods. J Clin Microbiol 1995;33:1479-85.
32. 32. Foulon W, Pinon JM, Stray-Pedersen B, Pollak A, Lappalainen M, Decoster A, et al. Prenatal diagnosis of congenital toxoplasmosis: a multicenter evaluation of different diagnostic parameters. Am J Obstet Gynecol 1999;181:843-7.
33. 33. Fricker-Hidalgo H, Pelloux H, Racinet C, Grefenstette I, Bost-Bru C, Goullier-Fleuret A, et al. Detection of Toxoplasma gondii in 94 placentae from infected women by polymerase chain reaction, in vivo, and in vitro cultures. Placenta 1998;19:545-9.
34. 34. Daffos F, Forestier F, Grangeot-Keros L, Capella-Pavlovsky M, Lebon P, Chartier M, et al. Prenatal diagnosis of congenital rubella. Lancet 1984;2:1-3.